| hsa-mir-130b |
PITA |
GO:0001525 |
angiogenesis |
2 |
14 |
158 |
18 |
0.2016721 |
| hsa-mir-301a |
PITA |
GO:0001525 |
angiogenesis |
2 |
14 |
158 |
18 |
0.2016721 |
| hsa-mir-301b |
PITA |
GO:0001525 |
angiogenesis |
2 |
14 |
158 |
18 |
0.2016721 |
| hsa-mir-130a |
PITA |
GO:0001525 |
angiogenesis |
2 |
14 |
158 |
18 |
0.2016721 |
| hsa-mir-454 |
PITA |
GO:0001525 |
angiogenesis |
2 |
14 |
158 |
18 |
0.2016721 |
| hsa-mir-544 |
TargetScan |
GO:0001525 |
angiogenesis |
3 |
14 |
158 |
53 |
0.755686 |
| hsa-mir-544b |
TargetScan |
GO:0001525 |
angiogenesis |
3 |
14 |
158 |
53 |
0.755686 |
| hsa-mir-130b |
PITA |
GO:0001568 |
blood vessel development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-301a |
PITA |
GO:0001568 |
blood vessel development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-301b |
PITA |
GO:0001568 |
blood vessel development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-130a |
PITA |
GO:0001568 |
blood vessel development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-454 |
PITA |
GO:0001568 |
blood vessel development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-544 |
TargetScan |
GO:0001568 |
blood vessel development |
5 |
20 |
158 |
53 |
0.7248758 |
| hsa-mir-544b |
TargetScan |
GO:0001568 |
blood vessel development |
5 |
20 |
158 |
53 |
0.7248758 |
| hsa-mir-130b |
PITA |
GO:0001701 |
in utero embryonic development |
3 |
10 |
158 |
18 |
0.01630758 |
| hsa-mir-301a |
PITA |
GO:0001701 |
in utero embryonic development |
3 |
10 |
158 |
18 |
0.01630758 |
| hsa-mir-301b |
PITA |
GO:0001701 |
in utero embryonic development |
3 |
10 |
158 |
18 |
0.01630758 |
| hsa-mir-130a |
PITA |
GO:0001701 |
in utero embryonic development |
3 |
10 |
158 |
18 |
0.01630758 |
| hsa-mir-454 |
PITA |
GO:0001701 |
in utero embryonic development |
3 |
10 |
158 |
18 |
0.01630758 |
| hsa-mir-544 |
TargetScan |
GO:0001701 |
in utero embryonic development |
3 |
10 |
158 |
53 |
0.4466412 |
| hsa-mir-544b |
TargetScan |
GO:0001701 |
in utero embryonic development |
3 |
10 |
158 |
53 |
0.4466412 |
| hsa-mir-130b |
PITA |
GO:0001944 |
vasculature development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-301a |
PITA |
GO:0001944 |
vasculature development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-301b |
PITA |
GO:0001944 |
vasculature development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-130a |
PITA |
GO:0001944 |
vasculature development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-454 |
PITA |
GO:0001944 |
vasculature development |
4 |
20 |
158 |
18 |
0.055917 |
| hsa-mir-544 |
TargetScan |
GO:0001944 |
vasculature development |
5 |
20 |
158 |
53 |
0.7248758 |
| hsa-mir-544b |
TargetScan |
GO:0001944 |
vasculature development |
5 |
20 |
158 |
53 |
0.7248758 |
| hsa-mir-130b |
PITA |
GO:0001955 |
blood vessel maturation |
0 |
3 |
158 |
18 |
0.3060302 |
| hsa-mir-301a |
PITA |
GO:0001955 |
blood vessel maturation |
0 |
3 |
158 |
18 |
0.3060302 |
| hsa-mir-301b |
PITA |
GO:0001955 |
blood vessel maturation |
0 |
3 |
158 |
18 |
0.3060302 |
| hsa-mir-130a |
PITA |
GO:0001955 |
blood vessel maturation |
0 |
3 |
158 |
18 |
0.3060302 |
| hsa-mir-454 |
PITA |
GO:0001955 |
blood vessel maturation |
0 |
3 |
158 |
18 |
0.3060302 |
| hsa-mir-544 |
TargetScan |
GO:0001955 |
blood vessel maturation |
1 |
3 |
158 |
53 |
0.2606627 |
| hsa-mir-544b |
TargetScan |
GO:0001955 |
blood vessel maturation |
1 |
3 |
158 |
53 |
0.2606627 |
| hsa-mir-130b |
PITA |
GO:0007155 |
cell adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-301a |
PITA |
GO:0007155 |
cell adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-301b |
PITA |
GO:0007155 |
cell adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-130a |
PITA |
GO:0007155 |
cell adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-454 |
PITA |
GO:0007155 |
cell adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-544 |
TargetScan |
GO:0007155 |
cell adhesion |
7 |
22 |
158 |
53 |
0.4689212 |
| hsa-mir-544b |
TargetScan |
GO:0007155 |
cell adhesion |
7 |
22 |
158 |
53 |
0.4689212 |
| hsa-mir-130b |
PITA |
GO:0009611 |
response to wounding |
4 |
27 |
158 |
18 |
0.1693807 |
| hsa-mir-301a |
PITA |
GO:0009611 |
response to wounding |
4 |
27 |
158 |
18 |
0.1693807 |
| hsa-mir-301b |
PITA |
GO:0009611 |
response to wounding |
4 |
27 |
158 |
18 |
0.1693807 |
| hsa-mir-130a |
PITA |
GO:0009611 |
response to wounding |
4 |
27 |
158 |
18 |
0.1693807 |
| hsa-mir-454 |
PITA |
GO:0009611 |
response to wounding |
4 |
27 |
158 |
18 |
0.1693807 |
| hsa-mir-544 |
TargetScan |
GO:0009611 |
response to wounding |
6 |
27 |
158 |
53 |
0.8751093 |
| hsa-mir-544b |
TargetScan |
GO:0009611 |
response to wounding |
6 |
27 |
158 |
53 |
0.8751093 |
| hsa-mir-130b |
PITA |
GO:0009653 |
anatomical structure morphogenesis |
7 |
35 |
158 |
18 |
0.02177679 |
| hsa-mir-301a |
PITA |
GO:0009653 |
anatomical structure morphogenesis |
7 |
35 |
158 |
18 |
0.02177679 |
| hsa-mir-301b |
PITA |
GO:0009653 |
anatomical structure morphogenesis |
7 |
35 |
158 |
18 |
0.02177679 |
| hsa-mir-130a |
PITA |
GO:0009653 |
anatomical structure morphogenesis |
7 |
35 |
158 |
18 |
0.02177679 |
| hsa-mir-454 |
PITA |
GO:0009653 |
anatomical structure morphogenesis |
7 |
35 |
158 |
18 |
0.02177679 |
| hsa-mir-544 |
TargetScan |
GO:0009653 |
anatomical structure morphogenesis |
11 |
35 |
158 |
53 |
0.5338298 |
| hsa-mir-544b |
TargetScan |
GO:0009653 |
anatomical structure morphogenesis |
11 |
35 |
158 |
53 |
0.5338298 |
| hsa-mir-130b |
PITA |
GO:0009790 |
embryo development |
5 |
22 |
158 |
18 |
0.02217801 |
| hsa-mir-301a |
PITA |
GO:0009790 |
embryo development |
5 |
22 |
158 |
18 |
0.02217801 |
| hsa-mir-301b |
PITA |
GO:0009790 |
embryo development |
5 |
22 |
158 |
18 |
0.02217801 |
| hsa-mir-130a |
PITA |
GO:0009790 |
embryo development |
5 |
22 |
158 |
18 |
0.02217801 |
| hsa-mir-454 |
PITA |
GO:0009790 |
embryo development |
5 |
22 |
158 |
18 |
0.02217801 |
| hsa-mir-544 |
TargetScan |
GO:0009790 |
embryo development |
4 |
22 |
158 |
53 |
0.9232192 |
| hsa-mir-544b |
TargetScan |
GO:0009790 |
embryo development |
4 |
22 |
158 |
53 |
0.9232192 |
| hsa-mir-130b |
PITA |
GO:0009792 |
embryo development ending in birth or egg hatching |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-301a |
PITA |
GO:0009792 |
embryo development ending in birth or egg hatching |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-301b |
PITA |
GO:0009792 |
embryo development ending in birth or egg hatching |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-130a |
PITA |
GO:0009792 |
embryo development ending in birth or egg hatching |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-454 |
PITA |
GO:0009792 |
embryo development ending in birth or egg hatching |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-544 |
TargetScan |
GO:0009792 |
embryo development ending in birth or egg hatching |
3 |
14 |
158 |
53 |
0.755686 |
| hsa-mir-544b |
TargetScan |
GO:0009792 |
embryo development ending in birth or egg hatching |
3 |
14 |
158 |
53 |
0.755686 |
| hsa-mir-130b |
PITA |
GO:0022610 |
biological adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-301a |
PITA |
GO:0022610 |
biological adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-301b |
PITA |
GO:0022610 |
biological adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-130a |
PITA |
GO:0022610 |
biological adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-454 |
PITA |
GO:0022610 |
biological adhesion |
1 |
22 |
158 |
18 |
0.7544539 |
| hsa-mir-544 |
TargetScan |
GO:0022610 |
biological adhesion |
7 |
22 |
158 |
53 |
0.4689212 |
| hsa-mir-544b |
TargetScan |
GO:0022610 |
biological adhesion |
7 |
22 |
158 |
53 |
0.4689212 |
| hsa-mir-130b |
PITA |
GO:0043009 |
chordate embryonic development |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-301a |
PITA |
GO:0043009 |
chordate embryonic development |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-301b |
PITA |
GO:0043009 |
chordate embryonic development |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-130a |
PITA |
GO:0043009 |
chordate embryonic development |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-454 |
PITA |
GO:0043009 |
chordate embryonic development |
3 |
14 |
158 |
18 |
0.0572347 |
| hsa-mir-544 |
TargetScan |
GO:0043009 |
chordate embryonic development |
3 |
14 |
158 |
53 |
0.755686 |
| hsa-mir-544b |
TargetScan |
GO:0043009 |
chordate embryonic development |
3 |
14 |
158 |
53 |
0.755686 |
| hsa-mir-130b |
PITA |
GO:0048514 |
blood vessel morphogenesis |
4 |
17 |
158 |
18 |
0.02807381 |
| hsa-mir-301a |
PITA |
GO:0048514 |
blood vessel morphogenesis |
4 |
17 |
158 |
18 |
0.02807381 |
| hsa-mir-301b |
PITA |
GO:0048514 |
blood vessel morphogenesis |
4 |
17 |
158 |
18 |
0.02807381 |
| hsa-mir-130a |
PITA |
GO:0048514 |
blood vessel morphogenesis |
4 |
17 |
158 |
18 |
0.02807381 |
| hsa-mir-454 |
PITA |
GO:0048514 |
blood vessel morphogenesis |
4 |
17 |
158 |
18 |
0.02807381 |
| hsa-mir-544 |
TargetScan |
GO:0048514 |
blood vessel morphogenesis |
3 |
17 |
158 |
53 |
0.8871167 |
| hsa-mir-544b |
TargetScan |
GO:0048514 |
blood vessel morphogenesis |
3 |
17 |
158 |
53 |
0.8871167 |
| hsa-mir-130b |
PITA |
GO:0048646 |
anatomical structure formation involved in morphogenesis |
3 |
17 |
158 |
18 |
0.1080682 |
| hsa-mir-301a |
PITA |
GO:0048646 |
anatomical structure formation involved in morphogenesis |
3 |
17 |
158 |
18 |
0.1080682 |
| hsa-mir-301b |
PITA |
GO:0048646 |
anatomical structure formation involved in morphogenesis |
3 |
17 |
158 |
18 |
0.1080682 |
| hsa-mir-130a |
PITA |
GO:0048646 |
anatomical structure formation involved in morphogenesis |
3 |
17 |
158 |
18 |
0.1080682 |
| hsa-mir-454 |
PITA |
GO:0048646 |
anatomical structure formation involved in morphogenesis |
3 |
17 |
158 |
18 |
0.1080682 |
| hsa-mir-544 |
TargetScan |
GO:0048646 |
anatomical structure formation involved in morphogenesis |
4 |
17 |
158 |
53 |
0.7381785 |
| hsa-mir-544b |
TargetScan |
GO:0048646 |
anatomical structure formation involved in morphogenesis |
4 |
17 |
158 |
53 |
0.7381785 |